The expression of epidermal growth factor receptor and Ki67 in primary and relapse nasopharyngeal cancer: a micro-evidence for anti-EGFR targeted maintenance therapy-Reference-Cited by-同舟云学术

The expression of epidermal growth factor receptor and Ki67 in primary and relapse nasopharyngeal cancer: a micro-evidence for anti-EGFR targeted maintenance therapy

Published:2011-07-23 Issue:3 Volume:29 Page:1448-1455
ISSN:1357-0560
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Yang Yanqin,Xuan Jize,Yang Zhiqiang,Han Anqin,Xing Ligang,Yue Jinbo,Hu Man,Yu Jinming

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12032-011-0028-4.pdf

Reference28 articles.

1. Fandi A, Altun M, Azli N, et al. Nasopharyngeal cancer, epidemiology, staging and treatment. Semin Oncol. 1994;21:382–97.

2. Lee AWM, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976–1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992;23:261–70.

3. Tan EH, Khoo KS, Wee J, et al. Phase II trial of paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma. Ann Oncol. 1999;10:235–7.

4. Caponigro F, Massa E, Manzione L, et al. Docetaxel and cisplatin in locally advanced or metastatic squamous-cell carcinoma of the head and neck: a phase II study of the Southern Italy Cooperative Oncology Group (SICOG). Ann Oncol. 2001;12:199–202.

5. Pignon JP, Bourhis J, Domenge C, et al. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data—MACH-NC collaborative group: meta-analysis of chemotherapy on head and neck cancer. Lancet. 2000;355:949–55.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cetuximab or nimotuzumab in combination with chemotherapy for treating recurrent/metastatic nasopharyngeal carcinoma: A meta‑analysis and systemic review;Oncology Letters;2023-04-05

2. Efficacy of concurrent chemoradiotherapy combined with nimotuzumab in the treatment of nasopharyngeal carcinoma with cervical lymph node metastasis;European Archives of Oto-Rhino-Laryngology;2022-12-29

3. Prognostic value of EGFR and p-EGFR in nasopharyngeal carcinoma;Medicine;2022-01-21

4. DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1α, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients;Radiotherapy and Oncology;2021-11

5. Prognostic Role of EGFR/p-EGFR in Patients With Nasopharyngeal Carcinoma: A Meta-Analysis;Frontiers in Oncology;2021-08-19